|
|
|
| Outcomes of liver transplantation as an oncologic surgery for different
primary liver cancers: A real-world, population-based study |
| Omar Abdel-Rahman |
Department of Oncology, Cross Cancer Institute and the University of Alberta, Edmonton, Canada
E-mail address: omar.abdelsalam@ahs.ca |
|
|
|
|
Abstract Although liver transplantation is likely used to treat individuals with end-stage liver disease because of non-neoplastic reasons, the adoption of liver transplantation in the management of primary liver cancer has been expanding in the past decades [1–3]. Prior population-based studies for liver transplantation, in the cancer sphere, focused on delineating the outcomes of patients with hepatocellular carcinoma (HCC) treated with transplantation versus other locoregional treatments [4–6]. However, little is known about the outcomes of patients with non-HCC primary liver cancers treated with liver transplantation. Understanding the outcomes of liver transplantation in different patient populations can have important implications for treatment decision-making for individual patients, but also for general policies underlying the transplant waitlist management and prioritization of listed patients. This study aimed to evaluate the outcomes of patients with different primary liver cancers treated with liver transplantation as an oncologic surgery.
|
|
|
|
|
|
|
|
|
2023, Vol. 22 
